Skip to main content

What the FDA labels say about taking them together

Nalbuphine and tranylcypromine

Nalbuphine's FDA label of December 31, 2025 names tranylcypromine in its drug interactions section; the tranylcypromine label PlainMeds reads does not name nalbuphine. The nalbuphine label: “Monoamine Oxidase Inhibitors (MAOIs) MAOI interactions with opioids may manifest as serotonin syndrome [see PRECAUTIONS;”

Check it at the source: the nalbuphine FDA label on DailyMed (effective December 31, 2025, Hospira, Inc.); the tranylcypromine FDA label on DailyMed (effective July 2, 2025, Advanz Pharma (US) Corp.).

What does the nalbuphine label say about tranylcypromine?

Nalbuphine label, drug interactions

Monoamine Oxidase Inhibitors (MAOIs) MAOI (e.g., phenelzine, tranylcypromine, linezolid) interactions with opioids may manifest as serotonin syndrome [see PRECAUTIONS;

Source: FDA drug label (Nalbuphine Hydrochloride), Hospira, Inc., effective December 31, 2025 (SPL set 6025e8d4-5083-4c3a-58a0-050e7b0b6150), via openFDA; the full label on DailyMed

What does the tranylcypromine label say about nalbuphine?

Tranylcypromine's label (effective July 2, 2025) does not name nalbuphine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (PARNATE), Advanz Pharma (US) Corp., effective July 2, 2025 (SPL set b72d8187-dfcc-4ea0-b5e9-c0be95b69a27), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

6Nalbuphine generic labelers
4Tranylcypromine generic labelers
NalbuphineTranylcypromine
Labeled forPainDepression
Boxed warningYesYes
Pharmacy cost (NADAC)$4.32 per mL 10 mg/mL ampul$0.591 per tablet 10 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?